Azitra (AZTR) Accumulated Expenses (2022 - 2026)

Azitra (AZTR) reported Accumulated Expenses of $270511.0 for Q1 2026, down 42.12% on a YoY basis from $467394.0 in Q1 2025, and up 36.98% quarter-over-quarter from $197484.0 in Q4 2025.

Azitra (AZTR) Accumulated Expenses (2022 - 2026) Analysis & Trends

Azitra has reported Accumulated Expenses for 5 years, with the latest figure at $270511.0 in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses fell 42.12% year-over-year to $270511.0; the trailing twelve-month figure through Mar 2026 stood at $270511.0 (down 42.12% YoY), and the FY2025 full-year result was $197484.0, down 67.24% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $270511.0, up from $197484.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $767721.0 in Q2 2023, with the low at $27082.0 in Q4 2022.
  • Historically, Accumulated Expenses has averaged $389624.5 across 5 years, with a median of $434103.0 in 2024.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses jumped 1316.69% — and 2025, when it slumped 67.24%.
  • Azitra's Accumulated Expenses stood at $27082.0 in 2022, then jumped by 1316.69% to $383668.0 in 2023, then jumped by 57.11% to $602787.0 in 2024, then tumbled by 67.24% to $197484.0 in 2025, then soared by 36.98% to $270511.0 in 2026.
  • The last three Accumulated Expenses figures came in at $270511.0 (Q1 2026), $197484.0 (Q4 2025), and $507329.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Azitra 20,900.00 20,900.00 -

Historic Data

Download Data
DateValue
Mar 31, 2026 270,511.00
Dec 31, 2025 197,484.00
Sep 30, 2025 507,329.00
Jun 30, 2025 513,166.00
Mar 31, 2025 467,394.00
Dec 31, 2024 602,787.00
Sep 30, 2024 486,981.00
Jun 30, 2024 434,103.00
Mar 31, 2024 348,930.00
Dec 31, 2023 383,668.00
Sep 30, 2023 57,963.00
Jun 30, 2023 767,721.00
Dec 31, 2022 27,082.00